Android app on Google Play

Jefferies Starts Cempra, Inc. (CEMP) at Buy

May 17, 2013 7:25 AM EDT Send to a Friend
Get Alerts CEMP Hot Sheet
Price: $9.92 -2.27%

Rating Summary:
    9 Buy, 1 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 13 | Down: 24 | New: 21
Trade CEMP Now!
Join SI Premium – FREE
Jefferies initiates coverage on Cempra, Inc. (NASDAQ: CEMP) with a Buy. PT $10.00.

The analyst comments, "Positives for CEMP include: (1) two antibiotic candidates targeting multi-drug resistance, thus well positioned to benefit from GAIN Act; (2) lead solithromycin in Ph3 for CABP, with data in 1H14; and (3) Taksta targeting niche indication in PJI, with Ph2 data in 4Q13. Challenges are: (1) limited capital hampering its ability to expedite Ph3 programs; and (2) likely continued need for financing in the absence of significant partnership."

For an analyst ratings summary and ratings history on Cempra, Inc. click here. For more ratings news on Cempra, Inc. click here.

Shares of Cempra, Inc. closed at $6.71 yesterday.




You May Also Be Interested In


Related Categories

New Coverage

Related Entities

Jefferies & Co

Add Your Comment